← Back to Search

Anti-viral

Open Label Treatment Arm for Hepatitis C (ELIMINATEC Trial)

Phase 4
Waitlist Available
Led By Ronald Nahass, MD
Research Sponsored by Id Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

ELIMINATEC Trial Summary

To demonstrate that colocation treatment of substance use disorder and Hepatitis C infection concurrently while proving addiction counselling will achieve increased duration of sobriety and elimination of Hepatitis C virus in study participants.

Eligible Conditions
  • Hepatitis C
  • Heroin Addiction

ELIMINATEC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cure rate of Hepatitis C Infection
Secondary outcome measures
Hepatitis C Reinfection Rate
Sobriety from Drug Use

ELIMINATEC Trial Design

1Treatment groups
Experimental Treatment
Group I: Open Label Treatment ArmExperimental Treatment1 Intervention
Treatment arm using Glecaprevir-pibrentasvir for treatment of all patients

Find a Location

Who is running the clinical trial?

AbbVieIndustry Sponsor
958 Previous Clinical Trials
502,354 Total Patients Enrolled
110 Trials studying Hepatitis C
32,799 Patients Enrolled for Hepatitis C
Id CareLead Sponsor
Ronald Nahass, MDPrincipal InvestigatorId Care

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study
Ronald Nahass 2018. "Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03364725.
All > Autoimmune Hepatitis > Hepatitis C
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top